Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLACONCANALDE
2023-504439-42-01Phase 2Withdrawn
- Sponsor
- Hospital Universitario 12 de Octubre
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Efficacy of cannabidiol on alcohol dependence, Psychological symptoms involved in alcohol consumption and 2 more. Planned start Sep 2025; status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2023-504439-42-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504439-42-01.